Our Team

Scientific Advisory Board
Robyn O'Hehir

Robyn O’Hehir has over 25 years’ research experience as an international allergy clinician and scientist. She is Professor/Director of the Department of Allergy, Immunology and Respiratory Medicine (Research) at Central Clinical School, Monash University, Melbourne and the Alfred Hospital, Melbourne, where her research team identified the critical components of the peanut allergy therapy being developed by Aravax. 

Kari C. Nadeau
M.D., PhD

Kari Nadeau is Professor of Pediatric Food Allergy at the Stanford School of Medicine, a Section Chief of Allergy and Asthma at the Stanford School of Medicine, and an endowed Professor under the Naddisy Family Foundation. 


She is also Director of the Sean N. Parker Centre for Allergy and Asthma Research.  Her Center’s mission is to transform the lives of patients and families through innovative science and compassionate care. 

Mark Larché

Mark Larché is Professor of Medicine at McMaster University, Canada.  He is also Chair in Lung Immunology at St. Joseph’s Healthcare, and the Canada Research Chair in Allergy & Immune Tolerance.  


Dr. Larché is an accomplished researcher and member of several societies including the British Society of Allergy and Clinical Immunology, the European Academy of Allergology and Clinical Immunology, and the American Academy of Allergy, Asthma and Immunology.


Tel: +61 (0)3 9657 0700
Email: info@aravax.com.au​
Address: Level 9, 31 Queen St

Melbourne, Victoria, 3000


Contact Us